Jasper Therapeutics (JSPR) News Today

$17.59

+0.23 (+1.32%)

(As of 02/9/2024 08:56 PM ET)

Source

Source	Headline
	Jasper Therapeutics, Inc. (NASDAQ:JSPR) Major Shareholder Velan Capital Investment Manag Purchases 350,000 Shares of Stock americanbankingnews.com - February 10 at 6:18 AM
	Velan Capital Investment Manag Purchases 350,000 Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR) Stock marketbeat.com - February 9 at 9:15 PM
	Jasper Therapeutics Announces Offering Pricing Details msn.com - February 7 at 12:37 PM
	Jasper Therapeutics Launches $50M Share Offering msn.com - February 7 at 12:37 PM
	Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference finance.yahoo.com - February 7 at 12:37 PM
	Jasper Therapeutics Shares Rise 20% After Offering Prices marketwatch.com - February 6 at 7:48 PM
	Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock finance.yahoo.com - February 6 at 9:47 AM
	Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting finance.yahoo.com - February 5 at 8:29 AM
	Jasper Therapeutics (JSPR) Surges 110% in a Month: Here's Why finance.yahoo.com - January 24 at 2:16 PM
	JSPR Feb 2024 10.000 call ca.finance.yahoo.com - January 23 at 4:19 PM
	marketbeat.com - January 17 at 10:18 AM
	Jasper Therapeutics, Inc.: Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones finanznachrichten.de - January 6 at 9:58 AM
	Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones finance.yahoo.com - January 5 at 9:09 AM
	marketbeat.com - January 4 at 6:00 AM
	Jasper Therapeutics to effect 1-for-10 reverse stock split msn.com - January 2 at 1:07 PM
	Jasper Therapeutics, Inc. Announces Reverse Stock Split finance.yahoo.com - January 2 at 1:07 PM
	Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023 finance.yahoo.com - December 10 at 3:04 PM
	Jasper Therapeutics: Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria finanznachrichten.de - November 30 at 4:10 PM
	Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria finance.yahoo.com - November 30 at 9:33 AM
	Jasper Therapeutics GAAP EPS of -$0.16 in-line msn.com - November 9 at 6:15 PM
	Jasper Therapeutics: Q3 Earnings Insights benzinga.com - November 9 at 1:14 PM
	Jasper Therapeutics Inc (JSPR) Reports Q3 2023 Financial Results and Business Progress finance.yahoo.com - November 9 at 1:14 PM
	Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - November 9 at 8:13 AM
	Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences finance.yahoo.com - November 8 at 8:34 PM
	Jasper Therapeutics Announces Oral Presentation of Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant at ASH 2023 finance.yahoo.com - November 2 at 12:51 PM
	Jasper Therapeutics Announces Appointment of Thomas G. Wiggans as Chairperson of the Board of Directors finance.yahoo.com - November 1 at 10:29 AM
	Jasper Therapeutics Inc. thestreet.com - October 23 at 1:40 PM
	Jasper Therapeutics, Inc.'s (NASDAQ:JSPR) high institutional ownership speaks for itself as stock continues to impress, up 25% over last week finance.yahoo.com - October 10 at 9:46 AM
	Jasper (JSPR) Up on FDA Nod to Begin Early-Stage Urticaria Study msn.com - October 10 at 9:46 AM
	Jasper Therapeutics Announces IND Clearance for Phase 1b/2a Study of Subcutaneous Briquilimab in Chronic Spontaneous Urticaria finance.yahoo.com - October 9 at 8:55 AM
	Jasper Therapeutics to Host Key Opinion Leader Webinar on the Potential of Briquilimab for Chronic Urticaria on October 11, 2023 finance.yahoo.com - October 9 at 8:55 AM
	Jasper Therapeutics Appoints Herb Cross As New CFO markets.businessinsider.com - September 25 at 9:49 AM
	Jasper Therapeutics to Present New Positive Data on Briquilimab Conditioning in Patients with Fanconi Anemia at the 2023 Fanconi Anemia Research Fund Scientific Symposium finance.yahoo.com - September 21 at 9:32 AM
	Jasper Therapeutics to Present at the Cantor Fitzgerald 2023 Global Healthcare Conference finance.yahoo.com - September 15 at 9:04 AM
	Jasper Therapeutics, Inc.: Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update finanznachrichten.de - August 12 at 6:50 AM
	Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - August 4 at 9:09 PM
	Carlyle Group Inc. Takes $15.77 Million Position in Jasper Therapeutics, Inc. (NASDAQ:JSPR) marketbeat.com - August 4 at 1:53 PM
	Jasper Therapeutics Strengthens Management Team with Key Appointments finance.yahoo.com - August 2 at 9:15 AM
	Brokers Issue Forecasts for Jasper Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:JSPR) marketbeat.com - July 14 at 7:22 AM
	Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus (JSPR) marketbeat.com - July 13 at 8:30 AM
	Jasper Therapeutics (NASDAQ: JSPR) fool.com - July 5 at 8:10 AM
	Jasper Therapeutics Announces First Patient Dosed in a Phase 1 Trial of Briquilimab in Lower-Risk Myelodysplastic Syndrome finance.yahoo.com - June 22 at 9:01 AM
	Jasper Therapeutics Director Awarded $128K Worth of Stock Options benzinga.com - June 21 at 1:43 PM
	Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors finance.yahoo.com - June 20 at 8:56 AM
	Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors finance.yahoo.com - June 20 at 8:56 AM
	Jasper Therapeutics, Inc. (NASDAQ:JSPR) Short Interest Down 18.0% in May marketbeat.com - June 16 at 6:55 PM
	Jasper Therapeutics appoints Edwin Tucker as CMO msn.com - June 13 at 6:18 PM
	Jasper Therapeutics Announces Appointment of Edwin J. Tucker, M.D., as Chief Medical Officer finance.yahoo.com - June 13 at 6:18 PM
	Jasper Therapeutics (JSPR) Gets a Buy from Credit Suisse markets.businessinsider.com - May 15 at 9:18 PM
	Where Jasper Therapeutics Stands With Analysts markets.businessinsider.com - May 15 at 4:18 PM

Get Jasper Therapeutics News Delivered to You Automatically

JSPR Media Mentions By Week

JSPR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JSPR
News Sentiment
▼
1.17

0.92
▲
Average
Medical
News Sentiment

JSPR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JSPR Articles
This Week
▼
10

1
▲
JSPR Articles
Average Week

Get Jasper Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:JSPR) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Jasper Therapeutics (JSPR) News Today

JSPR Media Mentions By Week

JSPR Media Sentiment

JSPR News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info